Clinical Trials in Denver

Showing 8761-8780 of 13,773 trials

A Continuous, Non-Invasive, Real-time Method for Estimating and Predicting Intracranial Hypertension

NCT01448681

There is statistically significant correlation between invasive measures of intracranial pressure (ICP) and non-invasive, real-time, continuous physiologic waveform data algorithms to predict ICP. Furthermore, characteristics within this physiologic waveform data will allow modeling for trend prediction of derived ICP information. Specific aims: 1. Develop models to estimate ICP and cerebral perfusion pressure (CPP) after traumatic brain injury in humans. 2. Predict and anticipate changes in ICP for preemptive management purposes. 3. Analyze characteristics of changes in ICP after treatment failure. 4. Analyze data to predict/anticipate confounding physiologic factors that affect ICP and its treatment. 5. Test the resulting models in real time.

Intracranial HypertensionElevated ICP (Intracranial Pressure)

University of Colorado, Denver32 participantsStarted Aug 2011

Denver, Colorado, United States

COMPLETEDPhase 3< 1 mile

A Study in Second Line Metastatic Colorectal Cancer

NCT01183780

The purpose of this study is to compare overall survival in participants with metastatic colorectal cancer treated with either ramucirumab and FOLFIRI or placebo and FOLFIRI.

Colorectal Cancer

Eli Lilly and Company1,072 participantsStarted Dec 2010

Sedona, Arizona, United States • Tucson, Arizona, United States • Fayetteville, Arkansas, United States +210 more locations

A Continuous, Non-Invasive, Real-time Method for Estimating and Predicting Intracranial Hypertension

A Study in Second Line Metastatic Colorectal Cancer

Find Trials by Condition in Denver

MRI to Detect Breast Tumors in Women

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Riociguat in Scleroderma Associated Digital Ulcers

Study of Ramucirumab in Ovarian Cancer

A Study in Advanced Solid Tumors

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear